High-dose Cyclophosphamide as an Effective Therapy for a Patient with Refractory Multiple Myeloma Relapsing after Autologous Stem Cell Transplantation
Year: 2005
Type: article
Study design: Case Report
Abstract: Alkylating agents are often used to treat patients with multiple myeloma (MM). However, it is not common for high-dose cyclophosphamide (CPM) therapy to be used as a treatment for MM. Herein, we report a case of refractory MM associated with hypercalcemia. We decided to give her high-dose CPM. After this treatment, the serum calcium level decreased and the tumor mass in the iliac bone was reduced. This therapy is potentially useful for patients with refractory MM.
Source: Internal Medicine
Institution: Niigata University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W1968183256